Wave Life Sciences, Inc.

WVE·NasdaqGM·Healthcare
Compare
3.2800−0.1800 (−5.20%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.4600
Open3.4600
Day range3.27003.4600
52-week range3.270021.7300
Off day high−5.20%
Off 52-week high−84.91%
Volume2.25M
Avg. volume (3M)3.09M
Market cap646.32M
EPS (TTM)-1.14
Forward P/E-2.83
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-1.43
Shares outstanding197.05M
Short interest11.62% of float
Earnings dateJul 30, 2026
Analyst target18.0556
Profit margin0.00%

Against its peers

Compare in full ›
WVE SLDB ARCT DSGN OBIO PRQR
Market cap 646.32M 719.48M 358.41M 682.77M 355.22M 228.61M
P/E (TTM) — — — — — —
Forward P/E -2.8 -3.9 -3.4 -6.7 -3.9 -3.5
Price/book 1.4 1.9 2.1 3.4 18.4 2.6
Dividend yield — — — — — —
1-year change −58.43% +7.70% −40.66% +64.80% +66.01% −34.15%
Today −5.20% −2.33% −8.22% −6.35% −0.67% −0.61%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Wave Life Sciences's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Solid Biosciences Inc.SLDB · Biotechnology 719.48M 6.71 −2.33%
Arcturus Therapeutics Holdings Inc.ARCT · Biotechnology 358.41M 12.61 −8.22%
Design Therapeutics, Inc.DSGN · Biotechnology 682.77M 10.91 −6.35%
Orchestra BioMed Holdings, Inc.OBIO · Biotechnology 355.22M 5.91 −0.67%
ProQR Therapeutics N.V.PRQR · Biotechnology 228.61M 1.6200 −0.61%
Biohaven Ltd.BHVN · Biotechnology 1.78B 11.81 −2.24%
Neurogene Inc.NGNE · Biotechnology 489.08M 24.44 −7.42%
Aura Biosciences, Inc.AURA · Biotechnology 678.23M 6.54 0.00%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Zevra Therapeutics, Inc.ZVRA · Boston, MA 672.22M 11.32 −0.61%
Olema Pharmaceuticals, Inc.OLMA · San Francisco, CA 643.98M 7.36 −5.88%
ProKidney Corp.PROK · Winston-Salem, NC 666.63M 1.6700 −4.02%
MiMedx Group, Inc.MDXG · Marietta, GA 704.86M 4.8300 +3.43%
Aura Biosciences, Inc.AURA · Boston, MA 678.23M 6.54 0.00%
Nuvectis Pharma, Inc.NVCT · Fort Lee, NJ 642.76M 19.69 −6.77%
Pharming Group N.V.PHAR · Leiden, Netherlands 680.18M 9.61 −1.84%
OmniAb, Inc.OABI · EmeryVille, CA 693.51M 4.7700 −0.42%

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
GE Vernova Inc.GEV · Cambridge, MA 265.48B 996.80 −0.79%
Moderna, Inc.MRNA · Cambridge, MAOdds 85.33B 213.74 −5.00%
Biogen Inc.BIIB · Cambridge, MA 33.90B 229.41 +1.64%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MAOdds 30.38B 227.02 −2.43%
Akamai Technologies, Inc.AKAM · Cambridge, MA 14.61B 101.65 −4.96%
HubSpot, Inc.HUBS · Cambridge, MA 11.43B 223.37 −2.16%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.11B 41.94 −0.59%
Relay Therapeutics, Inc.RLAY · Cambridge, MA 3.94B 17.98 +0.56%

The stocks whose daily moves over the past year went most closely with Wave Life Sciences's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Taysha Gene Therapies, Inc.TSHA · Correlation 0.35 1.35B 4.1400 −7.80%
Bicara Therapeutics Inc.BCAX · Correlation 0.34 1.15B 17.33 −0.97%
Voyager Therapeutics, Inc.VYGR · Correlation 0.32 139.87M 2.2700 −7.35%
Prime Medicine, Inc.PRME · Correlation 0.31 654.77M 3.6100 −9.52%
LB Pharmaceuticals IncLBRX · Correlation 0.31 1.16B 35.93 −3.47%

What visitors to Wave Life Sciences's page also look at.

Company Mkt cap Price Today
Scholar Rock Holding CorporatioSRRK 5.11B 41.94 −0.59%
Voyager Therapeutics, Inc.VYGR 139.87M 2.2700 −7.35%
CytomX Therapeutics, Inc.CTMX 527.32M 2.4200 −5.84%
Solid Biosciences Inc.SLDB 719.48M 6.71 −2.33%
REGENXBIO Inc.RGNX 512.92M 7.77 −3.72%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All WVE news ›
BioXconomy·

Dual-targeting siRNAs could treat more complex genetic diseases

An innovative bispecific siRNA design hits two genes at once, taking away one of cancer’s tricks for evading treatment. Some might say genetics research is in a rut. Biologists have made incredible biological and therapeutic discoveries…

Mugglehead·Positive

Wave Life Sciences outlines WVE-006 FDA path

A one-year biomarker analysis could support accelerated approval while the same study runs toward possible full approval. A single two-year study could support full U.S. approval of WVE-006, as Wave Life Sciences, Inc. NASDAQWVE said…

@gurufocus·Negative

WVE Initiates Coverage On Wave Life Sciences -- Buy Rating Annou

On October 03, 2023, analyst firm Ladenburg Thalmann has initiated coverage on Wave Life Sciences (WVE) with a rating of Buy. The current price target is set at $10.00. For further insights on the intrinsic value, you can explore the GF…

@gurufocus·

Wave Life Sciences (WVE) Shares Rise After FDA Confirms Registra

On October 01, 2026, Wave Life Sciences Inc (NASDAQ: WVE) saw its shares rise following the FDA’s confirmation of the registrational pathway for its investigational drug WVE-006, targeting alpha-1 antitrypsin deficiency (AATD). The company…

From articles in the 4Search news index.

In the news

16mentions in 30 days
14with it in the headline
Positivesentiment

Mentioned with

About Wave Life Sciences Wave Life Sciences5U.S. Food and Drug Administration5Wave Life Sciences Ltd.5Wave Life Sciences, Inc.5Astrazeneca4Further Development Candidate4Goldman Sachs4Johnson & Johnson4

People in the coverage

Mitch Edgeman6Danessa Lincoln5Paul Bolno5Danaher4Kim Johansen4Sarita Garza4

Themes

Announces7Biotech7Life6Sciences6Wave6Biotechnology5Cancer5FDA4

Most coverage from

  1. gurufocus.com2
  2. investingnews.com2
  3. quiverquant.com2
  4. tradingview.com2
  5. allsci.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.